Ayers, Emily http://orcid.org/0000-0003-3748-4507
Canderan, Glenda http://orcid.org/0000-0001-8388-9930
Williams, Michael E.
Keshavarz, Behnam
Portell, Craig A.
Wilson, Jeffrey M.
Woodfolk, Judith A.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI125056, AI160334)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 4 April 2023
Revised: 22 June 2023
Accepted: 11 July 2023
First Online: 26 July 2023
Competing interests
: Dr. Ayers is on the advisory board of ADC Therapeutics and Genentech. Drs. Canderan and Portell have no conflict of interest to disclose. Dr. Wilson received assay support from Thermo-Fisher/Phadia, unrelated to this project. Dr. Williams has clinical trial grant support from Janssen, Kymera, Pharmacyclics, TG Therapeutics and he is a consultant for Abbvie, Astra-Zeneca, Celgene, Gilead, Janssen, Kite, Kymera, TG Therapeutics. Dr. Williams is also part of the Longitudinal Assessment Committee of the American Board of Internal Medicine. Dr. Woodfolk receives research support from Regeneron Pharmaceuticals.